Wanbangde Pharmaceutical Holding Group Co., Ltd. (002082.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.65B
Enterprise Value8.92B
P/E Ratio-36.22
PEG Ratio0.03
Price/Sales Ratio7.22
Price/Book Ratio2.51
Enterprise/Revenue7.42
Enterprise/EBITDA-53.3

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.2
Operating Margin-0.17
AD

Management Effectiveness

Return On Assets-0.04
Return On Equity-0.07

Income Statement

Revenue1.12B
Revenue/Share1.44
Gross Profit1.14B
EBITDA-23.08M
Net Income-167.24M
Diluted EPS-0.32

Balance Sheet

Total Cash653.17M
Total Cash/Share1.07
Total Debt828.05M
Total Debt/Equity0.33
Current Ratio1.29
Book Value Per Share4.28

Price History

52-Week Change-28.37
52-Week High36.24
52-Week Low8.53
Moving Average 50 Days10.92
Moving Average 200 Days15.69

Statistics

Average Volume12.38M
Shares Outstanding611.69M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.27
Last Split Factor8:5
Last Split DateJune 10, 2008
AD